Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
212.96B
Market cap212.96B
Price-Earnings ratio
27.16
Price-Earnings ratio27.16
Dividend yield
2.27%
Dividend yield2.27%
Average volume
2.08M
Average volume2.08M
High today
$415.90
High today$415.90
Low today
$392.02
Low today$392.02
Open price
$408.91
Open price$408.91
Volume
3.01M
Volume3.01M
52 Week high
$447.03
52 Week high$447.03
52 Week low
$269.77
52 Week low$269.77

Stock Snapshot

The current Amgen(AMGN) stock price is $394.05, with a market capitalization of 212.96B. The stock trades at a price-to-earnings (P/E) ratio of 27.16 and offers a dividend yield of 2.27%.

On 2026-09-08, Amgen(AMGN) stock traded between a low of $392.02 and a high of $415.90. Shares are currently priced at $394.05, which is +0.5% above the low and -5.3% below the high.

The Amgen(AMGN)'s current trading volume is 3.01M, compared to an average daily volume of 2.08M.

In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.

In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.

AMGN News

Benzinga 16m
What's Going On With Amgen Stock Tuesday? - Benzinga

...

What's Going On With Amgen Stock Tuesday? - Benzinga
MarketWatch 2h
Healthcare sector leads losers, having worst day in more than a year

The healthcare sector is suffering a broad selloff led by Amgen's stock, with the losses enough to give up healthcare's lead as the top sector performer over th...

Healthcare sector leads losers, having worst day in more than a year
MarketWatch 2h
Amgen stock's record price plunge is wiping out more than 200 points from the Dow

Amgen's stock selloff is having a major impact on the price of the Dow, a price-weighted index, meaning a stock's price drives the index rather than its percent...

Amgen stock's record price plunge is wiping out more than 200 points from the Dow

Analyst ratings

50%

of 36 ratings
Buy
36.1%
Hold
50%
Sell
13.9%

More AMGN News

Nasdaq 3h
S&P 500 Movers: AMGN, HONIV

In early trading on Tuesday, shares of Honeywell International topped the list of the day's best performing components of the S&P 500 index, trading up 7.5%. Ye...

S&P 500 Movers: AMGN, HONIV
TipRanks 4h
Amgen, AstraZeneca report Phase 3 DeLLphi-305 study met primary endpoint

Amgen (AMGN) announced results from the Phase 3 DeLLphi-305 study, which met its primary endpoint at a pre-specified interim analysis, demonstrating a statistic...

24/7 Wall St. 5h
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Amgen, Baidu, Best Buy, Circle Internet, Corning, Intel, Lockheed Martin SpaceX, TeraWulf and More

Investing Here Are Tuesday’s Top Wall Street Analyst Research Calls: Amgen, Baidu, Best Buy, Circle Internet, Corning, Intel, Lockheed Martin SpaceX, TeraWulf a...

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Amgen, Baidu, Best Buy, Circle Internet, Corning, Intel, Lockheed Martin SpaceX, TeraWulf and More
The Wall Street Journal 8h
Stocks to Watch: Amgen, Nike, Bloom Energy

↘️ Amgen (AMGN): Shares of the biotechnology company, a major contributor to the Dow, shed more than 5% premarket after the Swiss drugmaker Novartis (CH:NOVN) s...

Stocks to Watch: Amgen, Nike, Bloom Energy
TipRanks 8h
Amgen downgraded to Market Perform from Outperform at BMO Capital

BMO Capital downgraded Amgen (AMGN) to Market Perform from Outperform with an unchanged price target of $450. The firm cites valuation for the downgrade, saying...

Nasdaq 1d
Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal

Shares of Amgen AMGN were down 5% in after-hours trading on Friday after Novartis NVS announced that the phase III Lp(a)HORIZON study evaluating the latter’s in...

Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal
TipRanks 1d
Novartis pelacarsen miss ‘not great on the margin for’ Amgen, says UBS

After Novartis (NVS) announced pelacarsen missed its primary endpoint of reducing cardiovascular events in the Phase 3 HORIZON study, UBS called the news “not g...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.